Monday, November 13, 2017

Repent, Sinners!

Apparently bioethicists have been paying no attention whatsoever to my sermons about the evils of taking money from pharma. I know, I know. "Even ethicists are on pharma's payroll?" you ask. "Yes, friends, it's true," I reply. "The world is a darker place than you can possibly know."  If you doubt it, just have a look at the bioethicists working for Pfizer: a three-time felon and architect of the evil Trovan meningitis study, 



BIOETHICS ADVISORY PANEL MEMBERS

David A. Boyko, MD, FFPM, Principal, David Boyko LLC; former Senior Vice President, Global Medical Affairs, Bristol-Myers Squibb, Princeton, NJ

Ames Dhai, MBChB, FCOG (S.A.), LLM. Head of the Bioethics University of the Witwatersrand Medical School, Director of the Steve Biko Centre for Bioethics, Durban, South Africa

Jeffrey P. Kahn, PhD, Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy, and Deputy Director for Policy and Administration, Johns Hopkins Berman Institute of Bioethics, Baltimore, MD

Johan Karlberg, MD, PhD, Managing Director, Clinical Trial Magnifier Limited, Hong Kong SAR, PR China; Vice-President, Alliance for Clinical Research Excellence and Safety (ACRES), Cambridge, MA

Bartha Knoppers, PhD, MA, LLB/BCL, Director of the Centre of Genomics and Policy, McGill University, Montreal (Quebec), Canada

James Lavery, PhD, Research Scientist, Li Ka Shing Knowledge Institute of St. Michael's Hospital and University of Toronto, Toronto (Ontario), Canada

Doris C. Schmitt, Doctor-Patient-Communication Consultant and Trainer, Medical Journalist, Board member Breast Cancer Biobank Foundation PATH, Konstanz, Germany

No comments:

Post a Comment